She received her undergraduate degree from the University of Illinois at Champaign - Urbana before conducting
neurological research at the University of Chicago and them spending several years at Abbott Labora...
SAN FRANCISCO, CA — Lennart Mucke, MD, who directs
neurological research at the Gladstone Institutes, next week will receive the ARCS Foundation's 2013 Pacesetter Award for his lifelong dedication to overcoming Alzheimer's disease — and for mentoring students to take a similar approach.
SAN FRANCISCO — July 15, 2012 — Lennart Mucke, MD, who directs
neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research.
«This work could have important ramifications for patients and families who suffer at the hands of neurodegenerative diseases such Alzheimer's, Parkinson's and Huntington's disease,» said Lennart Mucke, MD, who directs
neurological research at Gladstone.
SAN FRANCISCO, CA — Lennart Mucke, MD, who directs
neurological research at the Gladstone Institutes, today received the MetLife Foundation's 2013 Award for Medical Research in Alzheimer's Disease at a scientific briefing and awards ceremony in New York.
, who directs
neurological research at the Gladstone Institutes, next week will receive the ARCS Foundation's 2013 Pacesetter Award for his lifelong dedication to overcoming Alzheimer's disease — and for mentoring students to take a similar approach.
, who directs
neurological research at the Gladstone Institutes, today received the MetLife Foundation's 2013 Award for Medical Research in Alzheimer's Disease at a scientific briefing and awards ceremony in New York.
«It is estimated that more than 30 million people worldwide suffer from Alzheimer's disease and that number is expected to rise dramatically in the near future,» said Lennart Mucke, MD, who directs
neurological research at Gladstone, an independent and nonprofit biomedical - research organization.
«As a result, researchers have used the presence of IBs and heightened kinase activity as a proxy for measuring LRRK2's harmful effects, rather than measuring LRRK2 levels directly,» explained Dr. Finkbeiner, who is the associate director of
neurological research at Gladstone as well as a professor at the University of California, San Francisco, with which Gladstone is affiliated.
«Currently, we have no effective treatments to slow, prevent or halt Alzheimer's, from which more than 5 million people suffer in the United States alone,» said Dr. Mucke, who directs
neurological research at Gladstone and is a professor of neuroscience and neurology at the University of California, San Francisco, with which Gladstone is affiliated.
Other Gladstone colleagues who are also members of the AAP include Gladstone President, R. Sanders Williams, MD; Senior Investigator and President Emeritus Robert W. Mahley, MD, PhD; Senior Investigator Lennart Mucke, MD, who directs
neurological research at Gladstone, and Senior Investigator Eric Verdin involved in virology and immunology research.
Neurological research at Gladstone focuses on a host of devastating conditions, including Alzheimer's, frontotemporal dementia (FTD), Parkinson's and Huntington's disease, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and multiple sclerosis.
Not exact matches
While practicing medicine
at Stanford University, he won the American Academy of
Neurological Surgery's highest award for
research.
I am not surprised
at all
at the
neurological research showing that the same parts of the the brain, «light up.,» whether it is an image of a Mac or a religious deity.
«I think we are hard - wired to release our compassionate care when we see signs of vulnerability,» said Stephanie Brown, a psychologist
researching neurological links between motherhood and altruism
at Stony Brook University in New York.
Over the past five years, the Food and Agriculture Organization of the United Nations, the World Health Organization and the Cochrane Collaboration (an independent
research organization that receives funding from the government but none from the formula industry) have all published
research concluding that ARA and DHA are not effective
at improving infant's visual and
neurological development.
Prior to joining the NHLBI, Dr. Twery was a member of the
research faculty
at the University of Texas Medical Branch, Galveston, and for six years was a senior staff fellow
at the NIH's National Institute of
Neurological Disorders and Stroke.
But new
research holds out hope that drugs developed to treat other
neurological problems — notably epilepsy — could rein in the compulsive and blind drive to eat
at the core of the disorder.
The
research at Emory was supported by the National Institute of
Neurological Disorders and Stroke (NS079625) and the Emory Genetics Discovery Fund.
Many studies have linked more sleep to better memory, but new
research in fruit flies demonstrates that extra sleep helps the brain overcome catastrophic
neurological defects that otherwise would block memory formation, report scientists
at Washington University School of Medicine in St. Louis.
Those offering support for Dr. Samadani's
research include Richard G. Ellenbogen, MD, The Theodore S. Roberts Endowed Chair and professor and chairman of the Department of
Neurological Surgery
at University of Washington Medicine and co-chair of the Head, Neck and Spine Committee of the National Football League.
«This is incredibly alarming,» says Shai Silberberg, director of
research quality
at the National Institute of
Neurological Disorders and Stroke in Bethesda, Maryland, who was not involved in the study.
In one such study, Jordan Grafman, a cognitive neuroscientist
at the National Institute of
Neurological Disorders and Stroke in Bethesda, Maryland, and Jorge Moll, a neuroscientist
at the D'Or Institute for
Research and Education in Rio de Janeiro, dangled a pot of $ 128 in front of 19 subjects and gave them the opportunity to receive the money or to donate a portion to various social causes.
«This work is an example of how integrating basic science and clinical care may reveal privileged opportunities for biomedical
research,» said Matthew O. Hebb, M.D., Ph.D., FRCSC, a researcher involved in the work from the Departments of Clinical
Neurological Sciences (Neurosurgery), Oncology and Otolaryngology
at the University of Western Ontario in Ontario, Canada.
Tracy de Bernhardt Dunkin, Principal and CEO
at the WESC Foundation, said: «This is a tremendously exciting development for WESC and the culmination of five years» work to introduce learning and
research around
neurological visual impairment.
In a report that appears in PLOS BIOLOGY, Dr. Hugo Bellen and his colleagues
at Baylor College of Medicine and the Jan and Dan Duncan
Neurological Research Institute
at Texas Children's Hospital and BCM, and Dr. Chao Tong,
at the Life Sciences Institute and Innovation Center for Cell Biology, Zhejiang University in Hangzhou, China, find that mutations of human homologs (genes that carry out similar functions) of cacophony and its partner straightjacket (Cacna1a and Cacna2d2 respectively) cause defects in autophagy in neurons.
New
research by investigators
at the University of Massachusetts Medical School suggests the immune system plays an unsuspected and surprising role in the progression of Rett syndrome, a severe
neurological disorder affecting children.
The
research comes from the Infant Brain Imaging Study (IBIS), a collaborative effort by investigators
at the Montreal
Neurological Institute, and four clinical sites in the United States, coordinated to conduct a longitudinal brain imaging and behavioural study of infants
at high risk for autism.
This collaborative effort among Baylor, the Jan and Dan Duncan
Neurological Research Institute
at Texas Children's Hospital and Harvard Medical School is described in the latest online edition of the American Journal of Human Genetics.
Pozzo - Miller reflects that this new
research on LM22A - 4, combined with prior studies from the Katz lab, provides hope that
at least some
neurological and cognitive deficits in individuals with Rett could be improved by pharmacological treatment even after the onset of symptoms.
Researchers from Kent State University's College of Arts and Sciences, along with colleagues from the George Washington University, Yerkes National Primate
Research Center, Georgia State University, Barrow
Neurological Institute and the Icahn School of Medicine
at Mount Sinai, found that the brains of aged chimpanzees, our closest living relatives, show pathology similar to the human Alzheimer's disease brain.
This study was presented
at the Featured Clinical
Research Session I: Two - year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial from The Cardiothoracic Surgical Trials Network The Moderate Ischemic Mitral Regurgitation trial was supported by a cooperative agreement (U01 HL088942) funded by the National Heart Lung and Blood Institute, the National Institutes of
Neurological Disorders and Stroke of the National Institutes of Health (NIH), Bethesda, MD, and the Canadian Institutes of Health
Research.
«These exciting results provide new hope for developing drugs against an important molecular target in the brain,» said Roderick Corriveau, program director
at the National Institute of
Neurological Disorders and Stroke, which helped support the
research.
«This study opens a promising new avenue of
research into treatments that may prevent the development of epilepsy,» said Vicky Whittemore, PhD, a program director
at the National Institute of
Neurological Disorders and Stroke, who oversees the grants that funded this study.
Stephen Macknik, a neurophysiologist
at Barrow
Neurological Institute in Phoenix, says such
research could help determine the neural basis for prejudices and exclusionary behavior.
«This result has strong application potential» says Dr. Parise, who has just accepted a new position as
research scientist
at Oculus VR (Facebook): «A deep understanding of multisensory processing opens new clinical perspectives for
neurological syndromes that are associated with multisensory impairments, such as Autism Spectrum Disorder and Dyslexia.
The
research was conducted as part of an American - Russian neurosurgery collaboration led by Dr. Mark Preul at the Barrow Neurological Institute's Neurosurgery Research Department and Dr. Vadim Byvaltsev, a leading Russian neurosurgeon, and Chief of Neurosurgery in Irkutsk, Russia at the Irkutsk Scientific Center of Surgery and Traumatology and Department of Neurosurgery, Irkutsk State Medical Uni
research was conducted as part of an American - Russian neurosurgery collaboration led by Dr. Mark Preul
at the Barrow
Neurological Institute's Neurosurgery
Research Department and Dr. Vadim Byvaltsev, a leading Russian neurosurgeon, and Chief of Neurosurgery in Irkutsk, Russia at the Irkutsk Scientific Center of Surgery and Traumatology and Department of Neurosurgery, Irkutsk State Medical Uni
Research Department and Dr. Vadim Byvaltsev, a leading Russian neurosurgeon, and Chief of Neurosurgery in Irkutsk, Russia
at the Irkutsk Scientific Center of Surgery and Traumatology and Department of Neurosurgery, Irkutsk State Medical University.
«The grim prognosis is exactly why new
research is important,» said Bloch, who is an assistant professor of
neurological surgery
at the Northwestern Feinberg School of Medicine.
«When it comes to brain tumor
research, I picture our Northwestern Medicine team climbing a mountain and with every new discovery that shows the potential to prolong survival, we are establishing a new base camp,» said Andrew Parsa, MD, corresponding author of the study and chair of
neurological surgery
at Northwestern Memorial and the Michael J. Marchese Professor and chair of the department of
neurological surgery
at the Feinberg School.
New
research has also begun
at NYU Langone to test tDCS for other
neurological conditions, including Parkinson's disease.
«Very little
research» has been conducted to determine rates
at which veterans have been affected by
neurological diseases such as multiple sclerosis or Parkinson's disease, cancers, and reproductive problems, the panel said.
Dr. Frontera joins NYU Lutheran after serving as associate professor of medicine (neurology)
at the Cleveland Clinic Lerner College of Medicine's Cerebrovascular Center
Neurological Institute and the Cleveland Clinic Lerner
Research Institute's Department of Cellular and Molecular Medicine.
The findings, published today in the online journal PloS One, open new opportunities for gaining a greater understanding of Alzheimer's disease and other
neurological diseases and for developing therapies to halt its progression, according to senior author Karen E. Duff, PhD, professor of pathology (in psychiatry and in the Taub Institute for
Research on Alzheimer's Disease and the Aging Brain)
at CUMC and
at the New York State Psychiatric Institute.
He also held several positions of increasing leadership
at Praecis Pharmaceuticals, including Director of Cell Biology, where he initiated or contributed to the establishment of numerous
research projects focusing on the discovery of novel therapeutics for the treatment of cancer, inflammation, infectious disease, and
neurological disorders.
Issam Awad, MD, director of neurovascular surgery
at the University of Chicago Medicine, will lead a new program that melds the latest neuroscience
research with clinical practice to improve care for patients with
neurological diseases.
Funding was provided by the National Institutes of
Neurological Disorders and Stroke (1K08NS072233 - 01A1, 3R01 NS039074, 2R01 NS045091, NS083390), the Robert Packard Center for ALS
Research, Target ALS, the Roddenberry Stem Cell Program, the Koret / Taube Center for Neurodegenerative Disease, and the Protein Folding Diseases Initiative
at the University of Michigan.
Senior author Ken Nakamura, MD, PhD, an assistant investigator
at the Gladstone Institute of
Neurological Disease, says that conducting this
research in both healthy and diseased cells is essential for interpreting the findings.
The work and the researchers involved were supported by grants from the Dystonia Coalition, the Office of Rare Diseases
Research at the National Center for Advancing Translational Sciences and the National Institute of
Neurological Disorders and Stroke, the Bachmann - Strauss Dystonia & Parkinson Foundation, the Benign Essential Blepharospasm
Research Foundation, the Kavli Institute for Brain and Mind
at UCSD, the National Institute of Mental Health, and the National Science Foundation.
Here is where the University of Washington (UW) GRID Lab, led by Dr. Jeffrey Ojemann, Vice-Chair for
Research and Discovery and Professor of
Neurological Surgery
at UW Medicine and member of the Center for Sensorimotor Neural Engineering, comes in.
These highly competitive funds enable UCSF scientists to pursue
research aimed
at advancing understanding of human health and disease, and developing new therapies for
neurological diseases, cancer, diabetes, cardiovascular disease, and a host of other conditions.